4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-22-008106
Chairman & CEO sold 19,875 shares at an average $86.96 ($1,728,247)
- Chairman & CEO acquired 29,375 shares (option exercise)
- Chairman & CEO gave 9,500 shares (gift)
- Chairman & CEO gave 9,500 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
MUSSALLEM MICHAEL A · Chairman & CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-14 | Exercise or conversion : show line 1 in the form | +29,375 | $35.20 | $1,033,903 | 186,727.82 | D |
| 2022-06-14 | Sale : show line 2 in the form | −3,054 | $87.92 | $268,508 | 183,673.82 | D |
| 2022-06-14 | Sale : show line 3 in the form | −6,714 | $86.24 | $579,015 | 176,959.82 | D |
| 2022-06-14 | Gift : show line 4 in the form | −9,500 | 167,459.82 | D | ||
| 2022-06-14 | Sale : show line 5 in the form | −10,107 | $87.14 | $880,724 | 157,352.82 | D |
| 2022-06-14 | Gift : show line 6 in the form | +9,500 | 3,416,017 | I | ||
| Open-market sales · 19,875 sh · avg $86.96 · $1,728,247 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2022-06-14 | Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Acquire) | −29,375 | $35.20 | 2023-05-11 | 29,375 | 323,125 | D |
Loading xslF345X03/doc4.xml…